HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$7.25
Day range
$6.95 - $7.70
Year range
$3.42 - $7.70
Market cap
380.23M USD
Avg Volume
137.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.57M | 57.38% |
Operating expense | 18.67M | 23.80% |
Net income | -10.81M | -350.65% |
Net profit margin | -93.47 | -186.37% |
Earnings per share | -0.87 | -118.49% |
EBITDA | -8.85M | -3.44% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.69M | 100.98% |
Total assets | 36.46M | 32.70% |
Total liabilities | 63.19M | 31.89% |
Total equity | -26.72M | — |
Shares outstanding | 49.96M | — |
Price to book | -13.43 | — |
Return on assets | -57.95% | — |
Return on capital | -208.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.81M | -350.65% |
Cash from operations | -3.71M | 65.81% |
Cash from investing | -176.00K | -4.14% |
Cash from financing | 82.00K | -98.59% |
Net change in cash | -3.80M | 26.77% |
Free cash flow | -3.79M | 58.24% |
About
Founded
2009
Headquarters
Website
Employees
110
